@FiercePharma: Endo's lobbying yields a provision in House user-fee bill that could protect its Lidoderm patch--NYT. More | Follow @FiercePharma
> Sun Pharmaceuticals has recruited former Teva ($TEVA) CEO Israel Makov to serve as chairman, aiming to take advantage of his experience "globalizing businesses successfully," Managing Director Dilip Shanghvi said. Report
> KV Pharmaceutical ($KV-A) stock trading went through the roof Friday, with more than 2.9 million shares changing hands; the New York Stock Exchange is investigating. Story
> Endo Health Solutions ($ENDP) and Watson Pharmaceuticals ($WPI) settled their dispute over a generic version of Endo's Lidoderm patch, allowing Watson to launch a copy in 2013 under a royalty-and-supply agreement. News
> A $5.8 million pilot program in Hong Kong will subsidize expensive cancer drugs, with help from a $3.2 million contribution from GlaxoSmithKline ($GSK). Item
> In the focus on a genetic variant that may limit response to Sanofi ($SNY) and Bristol-Myers Squibb's ($BMY) bloodthinner Plavix, another cause of poor drug performance--noncompliance--might be overlooked. Article
> A federal task force has examined more data on hormone therapy for women and once again recommended against their use in those already past menopause. Story
> One in 10 prescriptions in Canada is written for off-label use, a study found. Report
Biotech News
@FierceBiotech: California's CIRM votes to shift stem cell grants toward clinical development side. More | Follow @FierceBiotech
@JohnCFierce: In fresh setback, Alnylam's most advanced drug flunks PhIIb RSV test. (Not what they need right now.) Item | Follow @JohnCFierce
@RyanMFierce: 23andMe's Google ties make today's news of the gene patent less surprising. News | Follow @RyanMFierce
> Trial vets at Flexion claim PhIIb success with lead osteoarthritis drug. Article
> China readies plan to spur its booming biotech sector. Story
> Bristol-Myers pushes latest blockbuster cancer drug prospect into ASCO spotlight. Report
> BMS creates global cancer drug collaboration. More
Medical Devices News
@FierceMedDev: For Biosensors, stents and an acquisition helped drive a stellar FY2012. Report | Follow @FierceMedDev
@MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce
> Foundation Medicine launches innovative cancer diagnostic. Story
> GE opens $80 million research center in China. Article
> FDA cites J&J's McNeil-PPC unit for limp lubricants. News
> U.S. House ramps up for device tax repeal vote next week. More
Drug Delivery News
@DamianFierce: Perhaps you can have too much of a good thing. Penn researchers say too many nanocarriers render treatments ineffective: Story | Follow @DamianFierce
> MIT develops needle-free jet injector. More
> Delivery firm seeks $3M for transdermal platform. Story
> West Pharma looks to cash in on biosimilar delivery. Report
> IntelGenx eyes FDA nod with anti-migraine film results. Item
Biomarkers News
> Biomarkers help select the most fertile donors. News
> The economics and value of genetic biomarkers. Story
> Fitness as a biomarker in breast cancer. More
> Bile duct biomarker screening for fluke-linked cancer. Article
And Finally... Aspirin and similar drugs may protect against skin cancer, researchers said. Report